Schonfeld Strategic Advisors’s SCP & CO Healthcare Acquisition Company Class A Common Stock SHAC Stock Holding History

Schonfeld Strategic Advisors’s Portfolio SHAC Stock Details SHAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-17,030	Closed	-$168K	–	3316
2022 Q3	$168K	Buy	17,030 +303	+2%	+$2.99K	﹤0.01%	2406
2022 Q2	$164K	Hold	16,727	–	–	﹤0.01%	1972
2022 Q1	$164K	Sell	16,727 -20,049	-55%	-$196K	﹤0.01%	2050
2021 Q4	$360K	Buy	36,776 +16,776	+84%	+$164K	﹤0.01%	1434
2021 Q3	$195K	Hold	20,000	–	–	﹤0.01%	1789
2021 Q2	$194K	Buy	+20,000	New	+$194K	﹤0.01%	1685

Schonfeld Strategic Advisors's SHAC Position: Q4 2022 in Review

Schonfeld Strategic Advisors sold out of SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) in Q4 2022, closing a stake of 17,030 shares — an estimated $168K sold.

Schonfeld Strategic Advisors first reported a position in SHAC in Q2 2021 and held it in 6 quarters. The position peaked at $360K in Q4 2021. 0 funds tracked by Wall St. Rank hold SHAC as of Q4 2022.

Schonfeld Strategic Advisors reported no remaining SCP & CO Healthcare Acquisition Company Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Schonfeld Strategic Advisors sold 17,030 SCP & CO Healthcare Acquisition Company Class A Common Stock shares in Q4 2022, an estimated $168K.
Schonfeld Strategic Advisors first reported a position in SCP & CO Healthcare Acquisition Company Class A Common Stock in Q2 2021 and held it in 6 quarters.
Schonfeld Strategic Advisors's SCP & CO Healthcare Acquisition Company Class A Common Stock position peaked at $360K in Q4 2021.
0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Class A Common Stock as of Q4 2022.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.